Cargando…
Broken drug markets in infectious diseases: Opportunities outside the private sector?
A subset of anti-infective drugs are increasingly unavailable for patients in the United States due to pricing or withdrawal from the market. Timely market solutions are needed. We assert that solutions to ensure access to some essential anti-infective agents lie outside capital markets and that pub...
Autores principales: | Alpern, Jonathan D., Dunlop, Stephen J., Stauffer, William M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6459471/ https://www.ncbi.nlm.nih.gov/pubmed/30973876 http://dx.doi.org/10.1371/journal.pntd.0007190 |
Ejemplares similares
-
Access to benznidazole for Chagas disease in the United States—Cautious optimism?
por: Alpern, Jonathan D., et al.
Publicado: (2017) -
Engaging with the Private Sector for Noncommunicable Disease Prevention and Control: Is it Possible to Create “Shared Value?”
por: Collins, Téa E., et al.
Publicado: (2023) -
Capacity Building of Private Sector Workforce for Public Health Services in India: Scope and Challenges
por: Sembiah, Sembagamuthu, et al.
Publicado: (2018) -
Drug-dispensing limits within Medicaid during the COVID-19 pandemic
por: Alpern, Jonathan D, et al.
Publicado: (2021) -
Attracting private sector inflows to close the financing gap for universal health coverage: What questions need to be answered?
por: Kwesiga, Brendan, et al.
Publicado: (2023)